Abstract:
Objective To sum the early clinical effect and experience advantages of totally thoracoscopic combined heart-lung surgery for mitral regurgitation combined with lung cancer.
Methods A retrospective analysis of clinical data was conducted on the first case of totally thoracoscopic minimally invasive aortic valve replacement combined with right upper lung lobe wedge resection performed in Jul. 2023 at the First Medical Center of the Chinese PLA General Hospital.
Results The patient underwent right upper lobectomy and aortic valve replacement under thoracoscopy simultaneously, and the surgical procedure was smooth, with good postoperative recovery. Follow-up at six months postoperatively, including echocardiography and chest CT, showed satisfactory results.
Conclusions The use of thoracoscopic minimally invasive surgery for the treatment of heart valve disease combined with lung cancer reduced the surgical trauma to the patients from multiple surgeries and the financial burden of multiple hospitalizations. It also demonstrated the safety and feasibility of this combined heart-lung surgical approach.
Key words:
Aortic valve replacement,
Totally thoracoscopic valve replacement,
Wedge resection of the lung lobe,
Combined heart-lung surgery
Hong Shen, Nan Cheng, Bo Yang, Hua Shen, Lin Zhang, Dong Li, Lianggang Li, Shiyong Dong, Shengli Jiang. Totally thoracoscopic invasive one-stage combined heart-lung surgery for aortic valve insufficiency and primary pulmonary carcinoma[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2024, 17(03): 160-163.